2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Humoral Hypercalcemia Of Malignancy: new trials by email Literature Review of Humoral Hypercalcemia Of Malignancy trials Research Report on Humoral Hypercalcemia Of Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium denosumab - Breast Cancer, Hypercalcemia of Malignancy | Phase 2 | Completed | Amgen | 33 | 2009-11-16 | 2018-10-17 |
| Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases monoclonal antibody CAL, zoledronic acid - Breast Cancer, Hypercalcemia of Malignancy | Phase 1 / Phase 2 | Completed | Chugai Pharmaceutical | 2002-11-01 | 2013-05-15 |
Breast Neoplasms (2) · Neoplasm Metastasis (2) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Endocrine Gland Neoplasms (1) · Head and Neck Neoplasms (1) · Hodgkin Disease (1) · Hypercalcemia (1) · Kidney Neoplasms (1) · Lung Neoplasms (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Neoplasms (1)
Breast Diseases (2) · Neoplasms by Site (2) · Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Blood Protein Disorders (1) · Bronchial Neoplasms (1) · Calcium Metabolism Disorders (1) · Carcinoma, Bronchogenic (1) · Cardiovascular Diseases (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1)
Antibodies, Monoclonal (1) · Denosumab (1) · Zoledronic Acid (1)
Amgen (1) · Chugai Pharmaceutical (1)
United States (2) · Canada (1) · France (1) · Italy (1) · Poland (1)